![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novavax Receives SARS Vaccine Funding From NIH
Novavax Receives SARS Vaccine Funding From NIH
Novavax, a specialty pharmaceutical company, has received a three-year contract from NIH to develop a Severe Acute Respiratory Syndrome (SARS) vaccine using its proprietary Virus Like Particle (VLP) technology. The grant for $1,069,789 over three years will assist Novavax in its development of a VLP vaccine for proof of concept studies in preparation for human trials.
Yahoo News (http://biz.yahoo.com/prnews/050204/nyf046_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct